Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...

CAMBRIDGE, Mass., February 07, 2025--eGenesis announces second patient successfully transplanted with genetically engineered ...

The second person ever has received a transplant with a genetically modified pig kidney.

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

The FDA has approved the first-ever clinical trials for pig kidney transplants in humans marking a breakthrough in tackling ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

IRVINE, Calif. - Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), a biotechnology company with a market capitalization of $284.54 million and a remarkable 170% stock return over the past year according to ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...

Eledon Pharmaceuticals (ELDN) announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a key component of the ...